Bioceres Crop Solutions Corp. BIOX
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 298.99M | 314.18M | 383.29M | 407.73M | 441.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 298.99M | 314.18M | 383.29M | 407.73M | 441.27M |
| Cost of Revenue | 184.66M | 197.92M | 233.46M | 238.31M | 265.30M |
| Gross Profit | 114.33M | 116.26M | 149.83M | 169.42M | 175.96M |
| SG&A Expenses | 100.76M | 105.57M | 103.13M | 103.49M | 102.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.26M | 3.70M | 7.16M | 16.04M | 16.98M |
| Total Operating Expenses | 300.05M | 319.19M | 361.00M | 375.02M | 401.33M |
| Operating Income | -1.05M | -5.01M | 22.29M | 32.71M | 39.94M |
| Income Before Tax | -58.46M | -60.56M | -17.73M | -3.31M | 5.85M |
| Income Tax Expenses | 4.38M | 1.03M | -9.50M | -6.45M | 2.08M |
| Earnings from Continuing Operations | -62.83 | -61.58 | -8.23 | 3.14 | 3.77 |
| Earnings from Discontinued Operations | 2.70M | 2.70M | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.85M | 3.55M | 204.20K | -603.00K | -1.27M |
| Net Income | -56.29M | -55.33M | -8.03M | 2.53M | 2.50M |
| EBIT | -1.05M | -5.01M | 22.29M | 32.71M | 39.94M |
| EBITDA | 11.81M | 7.61M | 40.87M | 50.89M | 57.92M |
| EPS Basic | -0.89 | -0.88 | -0.13 | 0.04 | 0.04 |
| Normalized Basic EPS | -0.11 | -0.13 | -0.18 | -0.05 | 0.03 |
| EPS Diluted | -0.89 | -0.88 | -0.13 | 0.03 | 0.03 |
| Normalized Diluted EPS | -0.11 | -0.13 | -0.18 | -0.06 | 0.02 |
| Average Basic Shares Outstanding | 252.24M | 251.66M | 251.26M | 251.31M | 251.33M |
| Average Diluted Shares Outstanding | 252.58M | 252.01M | 252.61M | 256.58M | 257.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |